Evidence map›Paper›PMID 36692026›Full record

ArticleEMBO molecular medicine2023

An in vivo avian model of human melanoma to perform rapid and robust preclinical studies.

Loraine Jarrosson, Stéphane Dalle, Clélia Costechareyre, Yaqi Tang, Maxime Grimont, Maud Plaschka, Marjorie Lacourrège, Romain Teinturier, Myrtille Le Bouar, Delphine Maucort-Boulch and 4 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Loraine Jarrosson *OncoFactory SAS, Faculté de Médecine et de Pharmacie, Lyon, France.ORCID 0000-0001-7105-7061
Stéphane Dalle *Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
Clélia CostechareyreOncoFactory SAS, Faculté de Médecine et de Pharmacie, Lyon, France.
Yaqi TangUniversité de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
Maxime GrimontUniversité de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
Maud PlaschkaUniversité de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
Marjorie LacourrègeOncoFactory SAS, Faculté de Médecine et de Pharmacie, Lyon, France.
Romain TeinturierOncoFactory SAS, Faculté de Médecine et de Pharmacie, Lyon, France.ORCID 0000-0001-9430-9508
Myrtille Le BouarCentre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
Delphine Maucort-BoulchCentre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
Anaïs EberhardtUniversité de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
Valérie Castellani *University of Lyon, University of Lyon 1 Claude Bernard Lyon 1, MeLiS, CNRS UMR5284, INSERM U1314, NeuroMyoGene Institute, Lyon, France.ORCID 0000-0001-9623-9312
Julie Caramel *Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.ORCID 0000-0002-8883-918X
Céline Delloye-Bourgeois *University of Lyon, University of Lyon 1 Claude Bernard Lyon 1, MeLiS, CNRS UMR5284, INSERM U1314, NeuroMyoGene Institute, Lyon, France.ORCID 0000-0002-7162-0034
Université Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic melanoma patients carrying a BRAF

Indexed as

MelanomaProto-Oncogene Proteins B-rafAnimalsDisease Models, AnimalHumansMitogen-Activated Protein Kinase KinasesMutationProtein Kinase InhibitorsMitogen-Activated Protein Kinase KinasesProtein Kinase InhibitorsProto-Oncogene Proteins B-rafavian modelmelanomapatient-Derived Xenograftspreclinical oncologytargeted therapies

Identifiers

PMID36692026
PMCPMC9994476
OpenAlexW4317871373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.